SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Director/PDMR Shareholding

11 Apr 2012 15:01

RNS Number : 1497B
Carillion PLC
11 April 2012
 

Carillion plc

(the Company)

 

2006 Long Term Incentive Plan

(known as the Leadership Equity Award Plan (LEAP))

 

Following achievement of the performance target relating to LEAP awards made on 7 April 2009, Carillion plc ordinary shares of 50p each were transferred on 10 April 2012 to Persons' Discharging Managerial Responsibilities (PDMRs) as set out in the table below.

 

No. of Ordinary Shares of 50p each vesting

No. of Ordinary Shares of 50p each sold on 10 April 2012 at £2.827808

Richard Howson, Group Chief Executive

21,934

-

Richard Adam, Group Finance Director

49,717

25,982

Staff Engstrom, Group Strategy Director

17,361

9,073

Adam Green, MD UK Construction

9,903

5,176

Susan Morton, Group HR Director

18,371

18,371

John Platt, MD Carillion Facilities Management

11,945

6,243

Richard Tapp, Company Secretary

19,413

19,413

 

All of the above PDMRs (except Mr. Howson - see below) sold shares received under the LEAP on 10 April 2012 at a price of £2.827808 per share in order, inter alia, to realise sufficient funds to settle resultant UK tax and social security liabilities arising from the transfer.

 

Mr. Howson was not tax resident in the UK when the shares were awarded under the LEAP.

 

The total number of Carillion shares in which each of these PDMRs has an interest following these transactions are as follows:

 

Total No. of Ordinary Shares

of 50p each*

Richard Howson, Group Chief Executive

63,779

Richard Adam, Group Finance Director

155,938

Staff Engstrom, Group Strategy Director

26,645

Adam Green, MD UK Construction

19,009

Susan Morton, Group HR Director

151,841

John Platt, MD Carillion Facilities Management

5,702

Richard Tapp, Company Secretary

150,653

 

*Each holding less than 0.04% of the issued share capital.

 

Tim George

Deputy Company Secretary

Carillion plc

11 April 2012

 

Tel: 01902 422431

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEALLFFEEAEFF
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.